- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
The UNDP Gender Equality Strategy 2018-2021, the third such strategy, provides a road map to elevate and integrate gender equality into all aspects of UNDP's work to reduce poverty, build resilience and achieve peace in communities and territories, helping to accelerate progress towards the 2030 Agenda.
In January 2019, there were 1,249 newly confirmed HIV-positive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP). Sixteen percent (196) had clinical manifestations of advanced HIV infection (WHO clinical stage 3 or 4) at the time of diagnosis.
The Strengthening HIV/AIDS Services for Key Populations in Papua New Guinea project generated an end of project series in three parts. The summary document presents results, success stories, recommendations and lessons learned. The second document shows the relationship between gender-based violence and HIV in the country and looks at the benefits of integrating clinical services. The third document is a set of annexes to the step-by-step process of integrating gender-based violence services with HIV services.
This document includes information on the relationship between GBV and HIV, the rationale behind GBV screening, the steps taken to integrate GBV programming across the Program in general and into HIV clinical services, lessons learned and recommendations, as well as resources and references for integration. Separate annexes contain additional materials and tools created by the Program. The diagram below summarizes the Program’s activities related to GBV.
These guidelines have been developed to provide updated, evidence-informed recommendations on tuberculosis (TB) infection prevention and control (IPC) in the context of the global targets of the Sustainable Development Goals (SDGs) and the World Health Organization (WHO) End TB Strategy. The notion and practice of IPC encompasses a set of broader, practical, evidence-based approaches to preventing the community from being harmed by avoidable infections, preventing health care-associated infections (HAI), implementing laboratory biosafety and reducing the spread of antimicrobial resistance (AMR).
The new UNAIDS report, Health, rights and drugs: harm reduction, decriminalization and zero discrimination for people who use drugs, shows that of the 10.6 million people who inject drugs in 2016, more than half were living with hepatitis C and one in eight were living with HIV. It outlines that ensuring that comprehensive harm reduction services are available—including needle–syringe programmes, drug dependence treatment and HIV testing and treatment—will kick-start progress on stopping new HIV infections among people who use drugs.
Based on privacy, confidentiality and security principles an Assessment Tool was developed to assess in country the extent that the confidentiality and security of personal health information is protected at facility and data warehouse/repository levels and whether national guidelines exist including privacy laws. A Manual on the use of the Assessment Tool has been produced and is available below.
With scaling-up of HIV and other health services in low- and middle-income countries, an increasing amount of personally identifiable health information is being collected at health facilities and stored in data repositories at local, regional and national levels. Countries need to protect the confidentiality and security of identifiable and de-identified personal health information, and this can be accomplished in part through the existence and implementation of relevant privacy laws, policies and programmes.
This document compiles examples of best practices at global, regional and country levels since the launch of the first edition of the Roadmap. It describes 36 examples from 24 countries (including 10 TB, two multidrug-resistant TB (MDR-TB) and four TB/ human immunodeficiency virus (HIV) high burden countries) from all the six WHO regions, two regional initiatives and 12 global initiatives. The examples are categorized according to the ten key actions from the 2013 Roadmap.
The 2018 United Nations General Assembly High-Level Meeting (HLM) on Tuberculosis and the current revision of the Roadmap for childhood tuberculosis together present an important moment to consolidate and advance advocacy, commitment, resource mobilization and joint efforts by all stakeholders to provide health care and address the burden of TB among children.